Chai Discovery · client: Pfizer
Pfizer announced a licensing agreement with Chai Discovery that gives it early access to the new Chai-3 AI platform, which could improve its ability to identify and design new drug…
Company lists
Research genomics, oncology therapeutics, medical devices, neurology health, listed and more: the companies building life sciences in California, with their founders, funding, team size and business models.
Funding, M&A, contract wins and launches involving 6,571 life sciences companies in California, last 24 months: 576 M&A deals · 527 funding rounds · 174 Contracts · 26 launches. Newest first; companies and investors link to their Fliar profiles. Latest event in our news feed: Jun 2026.
Pfizer announced a licensing agreement with Chai Discovery that gives it early access to the new Chai-3 AI platform, which could improve its ability to identify and design new drug…
Advanced NanoTherapies (ANT) has successfully closed a significant Series B funding round, garnering over $31 million.
announces that portfolio company Noctrix Health has been acquired by ResMed (NYSE: RMD), a global leader in sleep health and respiratory care, in a transaction valued at $340 million.
Hollister-Stier has agreed to filter and package an enzyme-replacement product for BioMarin Pharmaceutical Inc., of Novato, Calif.
Triomics has raised USD $22 million in Series B funding in a round led by Battery Ventures.
Butterfly, a LA-based private equity firm specializing in the food sector, has signed a definitive agreement to acquire a majority stake in Orgain, Inc., according to a press release.
It's also worth noting that Artiva Biotherapeutics wasn't far behind in fourth place after pricing a $300 million underwritten offering.
NEW YORK – Rallybio will merge with Avenzo Therapeutics to develop several precision oncology assets, including CDK2 and CDK4 inhibitors and bispecific antibody-drug conjugates (ADCs).
Veeva Systems announced it has acquired Ostro for approximately $100 million in cash and long-term equity retention grants.
Shares of Rallybio Corporation (RLYB) are gaining around 19 percent in Monday morning trading after the company announced an agreement to acquire Avenzo Therapeutics, Inc. through a…
Nexalin Technology Inc has closed its acquisition of PONM Inc from GreenLight Ventures LLC, securing the digital health platform that supports its HALO Clarity program and Nexalin…
US cloud software systems provider for the life sciences industry Veeva Systems (NYSE: VEEV), which has a market cap of $26 billion, has acquired Israeli clinical trial and data…
US pharmaceutical company Eli Lilly has taken over Engage Bio and has thus once again put the focus on the competition for non-viral DNA delivery.
Under the terms of the Merger Agreement, InnocsAI will merge with and into a newly formed wholly owned Delaware subsidiary of Liminatus, with the subsidiary surviving as a wholly owned…
Innovaccer Inc., a leading healthcare AI company, today announced the asset acquisition of CaduceusHealth, a nationally recognized revenue cycle management services provider.
Semler Scientific's merger added 5,048 bitcoin and medical-device operations to Strive.
Sensei Biotherapeutics reported first-quarter 2026 results and said the quarter was 'transformational,' highlighting the acquisition of Faeth Therapeutics and a concurrent $200 million…
We are pleased to submit this further improved, non-binding proposal to acquire 100% of the equity of the Company for $2.40 per share in cash, which represents an immediate 42% premium…
Standard Dental Labs has completed its acquisition of BRLIT Dental Laboratory, a Sarasota‑based lab with nearly five decades of history, marking a major milestone in the company's…
Soleno Therapeutics (NasdaqCM:SLNO) has entered into a definitive merger agreement with Neurocrine Biosciences, including a cash tender offer.
Robo.ai Inc. (NASDAQ:AIIO) said Thursday it agreed to acquire Neurovia AI Limited, a data processing and compression technology company, in a $100 million all-stock deal aimed at…
K.J. Harrison & Partners Inc acquired a new stake in shares of Natera, Inc. (NASDAQ:NTRA – Free Report) during the 4th quarter, according to the company in its most recent 13F filing…
Merck & Co (MSD) has completed its acquisition of Terns Pharmaceuticals, expanding its pipeline of treatments for chronic myeloid leukaemia (CML).
The Leverkusen take over the US biotech company Perfuse Therapeutics, which specializes in ophthalmology. The deal has a volume of up to 2.45 billion dollars
Belgian biopharma UCB is set to take over California-based Neurona Therapeutics for up to $1.15 billion.
Pursuant to the agreement, Phoenix Asia agreed to purchase 100% of the issued and outstanding equity interests of ACEA Pharma Inc., a wholly owned subsidiary of ACEA Therapeutics, in…
UCB, a global biopharmaceutical company, today announced signing of a definitive agreement under which it would acquire Candid Therapeutics (Candid), a privately held clinical-stage…
Gyre Therapeutics (Nasdaq: GYRE) has closed its acquisition of Cullgen Inc., a clinical-stage biotech focused on targeted protein degraders and degrader-antibody conjugates, in an…
UCB SA agreed to pay $2 billion up front to acquire bispecific T-cell engager (TCE)-maker Candid Therapeutics Inc. and lead BCMA/CD3 TCE asset cizutamig (CND-106), continuing big…
TOMI Environmental Solutions, Inc. today announced that it has executed a non-binding letter of intent (the “LOI”) to merge with Carbonium Core, Inc.
Few life sciences companies in California publish revenue, so this list compares what is on record instead: recorded equity funding, team size, revenue model, age and stage. The 50 companies below lead on recorded funding and team size among 4,502 active companies.

Developer of a screening platform for circulating tumor DNA to detect cancer
OncologyUS$2.00bn across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Liquid biopsy cancer detection via cfDNA methylation and fragment analysis
CPC C12Q1/6886, G16B40/20, G16H50/20Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of a deep learning platform for detecting circulating cancer-related markers
GenomicsUS$1.35bn across 7 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of implantable brain-computer interfaces
NeurologyUS$1.29bn across 6 disclosed equity rounds
Darker bars = larger roundsFocus: High‑density, hermetic neural electrode arrays and wireless implant communication systems.
CPC A61B34/20, A61B17/3468, G16H50/70Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Protein tracking and measuring tool for drug discovery
OncologyUS$1.16bn across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Automated vehicle intrusion barriers for rapid security deployment
CPC E01F13/123, G21K1/043Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

AI-enabled platform for drug discovery and development
Life sciences techEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of a photoimmunotherapy platform for treating cancer
OncologyUS$991.06m across 12 disclosed equity rounds
Darker bars = larger roundsFocus: Photodynamic therapy delivery devices and catheter systems for targeted cancer treatment
CPC A61K41/0071, G02B6/0008, A61K47/6851Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapeutic solutions for the treatment of diabetes
GenomicsUS$938.46m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapeutics modulating alternative splicing for disease treatment
NeurologyUS$778.00m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapeutics for immune-mediated inflammatory and fibrotic diseases
ImmunologyUS$730.00m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapeutic for central nervous system disorders
NeurologyUS$698.50m across 6 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of benchtop DNA sequencer for research applications
Life sciences platforms and toolsUS$678.30m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Advanced optical flow cells, reagents, and data processing for next‑gen DNA sequencing
CPC C12Q1/6874, C12Q1/6869, G01N15/1436Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Platform offering quality management solutions for health sciences organizations
Healthcare itEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of machine learning platform for drug discovery and development
Artificial intelligenceUS$643.21m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: AI-driven biomedical data analysis and disease modeling for drug discovery and diagnostics
CPC G06V20/69, G06T7/0012, G16B40/20Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of immune cell therapies for cancer treatment
OncologyUS$631.16m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of microbial nitrogen products designed for crop nutrition enhancement
Crop techUS$618.08m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Microbial nitrogen fixation technologies for enhanced crop nutrition and yield.
CPC C05F11/08, A01N63/20, C12N15/74Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Manufacturer of a medical device for cell-based therapy
Life sciences platforms and toolsUS$612.00m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in transport & manufacturing processes
CPC B01L3/502715, C12M41/48, C12M35/02Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of bioinformatics platform to find treatment for cancer and other diseases
Healthcare itUS$607.58m across 10 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of high-throughput NGS instrument for research
GenomicsFocus: Patents concentrated in chemistry & materials
CPC C12Q1/6874, C12Q1/6869, C12Q1/6837Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of access catheters for cardiovascular diagnosis and treatment
Cardiac and vascular disordersUS$596.00m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Robotic-assisted neurovascular catheter systems for precise multi‑catheter interventions
CPC A61B17/22, A61B34/37, A61B34/30Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of digital sequencing technology for cancer detection
GenomicsUS$557.50m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Liquid biopsy cfDNA sequencing and analysis for cancer detection and monitoring
CPC C12Q1/6886, C12Q1/6869, C12Q1/6806Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of healthcare data platforms and artificial intelligence agent software
Big data analyticsUS$557.35m across 8 disclosed equity rounds
Darker bars = larger roundsFocus: Integrating and analyzing de‑identified healthcare data across clouds for clinical decision support
CPC G16H10/60, G06F21/6254, G06F8/36Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of drugs for immunology
ImmunologyUS$550.00m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Therapeutic antibodies targeting inflammatory pathways for autoimmune skin and joint diseases
CPC A61K39/39591, C07K16/244, A61P17/00Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of biology-guided radiotherapy system
OncologyUS$542.31m across 8 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of chimeric antigen receptor cell therapy to treat cancer
ImmunotherapyUS$531.77m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Engineering allogeneic CAR‑T cells with immune‑evasion, switch receptors, and dosing technologies
CPC C12N5/0636, C07K14/715, A61K35/17Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapeutics for the treatment of auto-immune disease
ImmunologyUS$529.00m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: TYK2 kinase inhibitor compounds and formulations for inflammatory disease treatment.
CPC C07D401/14, C07D401/12, C07D498/22Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of a cloud based clinical trail management tool for researchers
Life sciences techUS$518.45m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: Digital health data integration, remote patient monitoring, and HIPAA compliance automation
CPC G16H50/20, G06Q10/0639, G16H80/00Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of genetic bio-markers in neurological, metabolic, and renal diseases
GenomicsUS$496.00m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of CAR- T therapy for cancer treatment
ImmunotherapyFocus: Engineering and manufacturing of enhanced CAR‑T cells and cytokine gene therapies
CPC C12N5/0636, C07K14/7051, C07K14/71Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of end-to-end Virtual clinic offering cancer-based solutions
Employee health itUS$491.44m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: Enabling cross-device social network content sharing and live streaming
CPC H04L12/1827, H04L65/60Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of antibodies to modulate the activity of immunosuppressive cells in the tumor microenvironment
ImmunotherapyUS$475.00m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of cloud-based genome informatics & data management platform
GenomicsUS$472.55m across 8 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in computing, sensing & instrumentation
CPC G16B50/00, G16B30/10, G16B20/00Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of hemodialysis machine with touchscreen display
NephrologyUS$457.87m across 7 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapeutics for cancer treatment
OncologyUS$445.85m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of Allogeneic cell therapy for cancer, autoimmune diseases and genetic blood disorders
Cell therapyUS$442.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of a genomic database for clinical research
Healthcare booking platformsUS$435.00m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Genomic sequencing data management and cardiac genomics diagnostics analytics
CPC C12N15/8273, B21C37/121, G16B20/20Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of point of care ultrasound ecosystem with AI-powered diagnostic and workflow tools
Imaging diagnosticsUS$428.39m across 8 disclosed equity rounds
Darker bars = larger roundsFocus: Utility pole repair, reinforcement, and load‑transfer hardware for infrastructure maintenance
CPC E04G23/0225, E04H12/085, E04H12/2292Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of biologics to treat hepatitis B infection
Infectious diseasesUS$415.00m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Antiviral nucleoside analogs/capsid inhibitors and neurosteroid-based CNS therapeutics
CPC A61K31/7076, C07J17/00, A61K31/568Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of antibody-based therapeutics for the treatment of cancer
OncologyUS$412.30m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of a cloud-based bioinformatics platform for biotech research
GenomicsUS$411.90m across 8 disclosed equity rounds
Darker bars = larger roundsFocus: Cloud-based bioprocess workflow and molecular design data management platform.
CPC G05B19/41865, G16C20/40, G06F21/6227Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Company provides healthcare analytics and value-based payments platform services
Healthcare itUS$410.97m across 8 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of instrument systems and software for real-time sequencing of single-molecules
GenomicsUS$395.00m across 5 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of precision medicine, preventative health assessments, and longevity care
Data as a serviceUS$408.72m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: Integrative multi‑omic analytics and genomic risk prediction for precision health diagnostics
CPC G16B40/00, C12Q1/6869, G16B20/20Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of drugs for muscle, bone, and joint diseases
Rare diseasesUS$406.00m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Anti‑sclerostin biologics for osteoporosis and bone‑mass therapies
CPC C07K16/468, C07K16/18, C07K16/22Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of therapies for metabolic health in chronic disease patients
Healthcare itUS$401.78m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: Cable‑suspended overland material handling and transport conveyor systems
CPC B65G21/04Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Business energy price comparison website helping UK businesses save on energy bills
Life sciences platforms and toolsUS$390.01m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: Algal biofuel production and photosynthetic synthesis of high‑value chemicals.
CPC C12N1/12, C11B1/02, C12Q1/6895Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of cell-free cancer liquid biopsy test
GenomicsUS$388.62m across 7 disclosed equity rounds
Darker bars = larger roundsFocus: cfDNA methylation quantification and sequencing assay quality control for diagnostics
CPC C12Q1/6876, G16B40/00, C12Q1/6883Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of implantable neuromodulation devices for inflammatory diseases
OrthopedicsUS$388.17m across 10 disclosed equity rounds
Darker bars = larger roundsFocus: Bioelectronic neuromodulation devices targeting vagus nerve for chronic inflammation control
CPC A61N1/36053, A61N1/3787, A61N1/0556Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of hearing aids for people with less hearing power
Ent disordersUS$387.90m across 12 disclosed equity rounds
Darker bars = larger roundsFocus: Contact hearing aids with microactuator ear‑canal transducers and advanced noise reduction
CPC H04R25/606, H04R25/554, H04R25/456Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Digital gene editing technologies for drug development
Life sciences techUS$376.37m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Advanced genome editing tools: engineered nucleases, CRISPR-Cas systems, and base editors.
CPC C12N9/22, C12N15/907, C12N15/102Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of precision medicines for treating lung related diseases
PulmonologyUS$371.00m across 7 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
No matching company in this list.
This page shows the top 50. Radar has the complete, filterable list with contacts and live company signals.
Open life sciences in California on RadarBrowse life sciences companies in California for genomics, drug discovery, oncology, and research tools. Find life sciences companies and life science technology for health research and development.
Companies building genomics, laboratory tools, and research platforms.

Developer of a screening platform for circulating tumor DNA to detect cancer
Oncology
Provider of a deep learning platform for detecting circulating cancer-related markers
Genomics
Protein tracking and measuring tool for drug discovery
Oncology
AI-enabled platform for drug discovery and development
Life sciences tech
Developer of therapeutic solutions for the treatment of diabetes
GenomicsCompanies developing cancer diagnostics, therapies, and immunotherapy.

Developer of a screening platform for circulating tumor DNA to detect cancer
Oncology
Provider of a deep learning platform for detecting circulating cancer-related markers
Genomics
Protein tracking and measuring tool for drug discovery
Oncology
Developer of a photoimmunotherapy platform for treating cancer
Oncology
Developer of therapeutic solutions for the treatment of diabetes
GenomicsCompanies offering medical devices, diagnostics, and clinical monitoring products.

Provider of access catheters for cardiovascular diagnosis and treatment
Cardiac and vascular disorders
Provider of hemodialysis machine with touchscreen display
Nephrology
Developer of point of care ultrasound ecosystem with AI-powered diagnostic and workflow tools
Imaging diagnostics
Provider of hearing aids for people with less hearing power
Ent disorders
Endoluminal solutions for digestive diseases, restoring anatomy and improving patient outcomes
GastroenterologyCompanies focused on neurological conditions, healthcare IT, and disease management.

Developer of therapeutic solutions for the treatment of diabetes
Genomics
Developer of therapeutics modulating alternative splicing for disease treatment
Neurology
Developer of healthcare data platforms and artificial intelligence agent software
Big data analytics
Company provides healthcare analytics and value-based payments platform services
Healthcare it
Provider of therapies for metabolic health in chronic disease patients
Healthcare itBrowse publicly listed life sciences companies.

Developer of a screening platform for circulating tumor DNA to detect cancer
Oncology
Protein tracking and measuring tool for drug discovery
Oncology
Developer of therapeutic for central nervous system disorders
Neurology
Provider of bioinformatics platform to find treatment for cancer and other diseases
Healthcare it
Developer of digital sequencing technology for cancer detection
GenomicsBrowse newer life sciences companies.

AI-enabled platform for drug discovery and development
Life sciences tech
Developer of therapeutics for immune-mediated inflammatory and fibrotic diseases
Immunology
Developer of therapeutics for cancer treatment
Oncology
Provider of online science magazine
Ophthalmology
Developer of brain-computer interfaces to maximize human ability, agency, experience
NeurologyFind life sciences companies with hiring activity.

Provider of implantable brain-computer interfaces
Neurology
AI-enabled platform for drug discovery and development
Life sciences tech
Developer of a photoimmunotherapy platform for treating cancer
Oncology
Developer of benchtop DNA sequencer for research applications
Life sciences platforms and tools
Platform offering quality management solutions for health sciences organizations
Healthcare itThe most-installed Android apps published by life sciences companies headquartered in California — 48.6M installs between them. 115 companies on this page publish at least one app; each company (legal entity) appears once, with its most-installed app.
The figures on this page come from Fliar’s company, funding, hiring and news data. Use it through the Investor Intelligence API and company data exports, or explore every company, founder and investor in Radar.
22,455 recorded equity rounds have gone to 27,407 life sciences companies in the United States — how much, at which stage, into which sub-sectors, from whom, and how California compares. Debt, IPO and grant rounds are excluded.
US$13.54bn
US$37.38bn
5,603 rounds in the United States
last 24 months
Bars show US$ raised; the number under each year is equity rounds. 2026 is year to date. The peak year was 2021, with US$45.29bn across 1383 rounds.
Equity rounds over the last five years, 6,571 life sciences companies in California among 27,407 in the United States.
Each deal appears in the events strip at the top of the page.
Go deeper in the life sciences landscape reports:
Life Sciences Industry Landscape of the United StatesThe financials above are one chapter. The full life sciences landscape of California maps the whole industry — every segment, the capital behind it, the talent market and where the next opportunities are.
1,597 life sciences companies in California have recorded equity funding, US$108.67bn in total. Totals and round dates describe the historical record; they are not current valuations.
Largest recorded equity totals, with the latest recorded round.
OncologyDeveloper of a screening platform for circulating tumor DNA to detect cancer
Founders
Details not available
GenomicsProvider of a deep learning platform for detecting circulating cancer-related markers
NeurologyProvider of implantable brain-computer interfaces
OncologyProtein tracking and measuring tool for drug discovery
Life sciences techAI-enabled platform for drug discovery and development
OncologyDeveloper of a photoimmunotherapy platform for treating cancer
GenomicsDeveloper of therapeutic solutions for the treatment of diabetes
NeurologyDeveloper of therapeutics modulating alternative splicing for disease treatment
ImmunologyDeveloper of therapeutics for immune-mediated inflammatory and fibrotic diseases
NeurologyDeveloper of therapeutic for central nervous system disorders
Life sciences platforms and toolsDeveloper of benchtop DNA sequencer for research applications
Healthcare itPlatform offering quality management solutions for health sciences organizations
Artificial intelligenceDeveloper of machine learning platform for drug discovery and development
OncologyDeveloper of immune cell therapies for cancer treatment
Crop techDeveloper of microbial nitrogen products designed for crop nutrition enhancement
Life sciences platforms and toolsManufacturer of a medical device for cell-based therapy
US$2.00bn across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Liquid biopsy cancer detection via cfDNA methylation and fragment analysis
CPC C12Q1/6886, G16B40/20, G16H50/20Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$1.35bn across 7 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$1.29bn across 6 disclosed equity rounds
Darker bars = larger roundsFocus: High‑density, hermetic neural electrode arrays and wireless implant communication systems.
CPC A61B34/20, A61B17/3468, G16H50/70Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$1.16bn across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Automated vehicle intrusion barriers for rapid security deployment
CPC E01F13/123, G21K1/043Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$991.06m across 12 disclosed equity rounds
Darker bars = larger roundsFocus: Photodynamic therapy delivery devices and catheter systems for targeted cancer treatment
CPC A61K41/0071, G02B6/0008, A61K47/6851Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$938.46m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$778.00m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$730.00m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$698.50m across 6 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$678.30m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Advanced optical flow cells, reagents, and data processing for next‑gen DNA sequencing
CPC C12Q1/6874, C12Q1/6869, G01N15/1436Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$643.21m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: AI-driven biomedical data analysis and disease modeling for drug discovery and diagnostics
CPC G06V20/69, G06T7/0012, G16B40/20Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$631.16m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$618.08m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Microbial nitrogen fixation technologies for enhanced crop nutrition and yield.
CPC C05F11/08, A01N63/20, C12N15/74Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$612.00m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in transport & manufacturing processes
CPC B01L3/502715, C12M41/48, C12M35/02Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Meet the people behind life sciences companies in California. 3,133 of 4,502 companies list founders or leaders; where a public LinkedIn profile matches exactly, the expanded profile shows the photo, headline, location and education.
Companies whose recorded headcount rose the most between the two most recent team-size snapshots. A larger team is a signal of momentum, not of profitability.
Life sciences platforms and toolsDevelops in-vivo animal model for R&D applications
Founders
Details not available
DermatologyProvider of science-focused brand addressing the aging process of hair with a holistic approach
Founders
Details not available
Life sciences platforms and toolsDeveloper of the device for 3D imaging of biological samples
Founders
Details not available
OncologyDeveloper of early diagnostic tools for cancer
GenomicsProvider of genomic analysis tools, instrumentation and services
Dental disordersDevelops innovative technologies and manufacture and market products for the dental and medical professions
Founders
Details not available
ImmunotherapyDeveloper of immunotherapy to treat cancer, infectious, and inflammatory diseases
Cardiac and vascular disordersTranscatheter heart valve technology
Cardiac and vascular disordersDesigns and manufactures for endovascular aortic repair equipment
GenomicsContract research organization for cell culture product and animal model manufacturer
ObesityDeveloper of therapies for chronic lifestyle diseases using endogenous metabolites
OphthalmologyDeveloper of medical device for the treatment of glaucoma
Founders
Details not available
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$146.51m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: NK cell CAR immunotherapy development, epigenetic enhancement, and scalable cell manufacturing
CPC C12N5/0646, A61K35/17, A61K40/15Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$142.37m across 5 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$260.95m across 7 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Life sciences companies in California with at least one woman on the founding team. Expand a profile to meet the founders; teams can include both women and men.
Natural language processingProvides AI-enabled data analytics tool for the healthcare industry

Wearable technologyProvider of a wearable device for glucose monitoring
GenomicsProvider of home-based genetic test for individuals
Life sciences platforms and toolsDeveloper of a semiconductor-based DNA synthesis platform
GenomicsDeveloper of genomics-based diagnostics for cancer
Food techProvider of prepared meals, snacks, and juices with delivery options
Life sciences techProvider of a cloud based clinical trail management tool for researchers
Disease self managementEEG system for the diagnosis of seizures
GenomicsProvider of genomic diagnostic products for the treatment of cancer
Life sciences techReal-world health data insights for better healthcare decisions and research
GenomicsProvider of molecular diagnostics platform by using CRISPR technology
Microbiome therapeuticsDeveloper of synbiotics for simulating gut microbiome

Focus: AI-driven automation of clinical workflow and health‑expert conversational assistance.
CPC G16H10/20, G16H80/00Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$52.50m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Continuous glucose monitoring sensors, data transmission, and glycemic management software
CPC A61B5/14532, A61B5/14865, A61B5/1495Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$189.56m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in computing, sensing & instrumentation
CPC G16B20/20, C12Q1/6827, C12Q1/6869Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$320.76m across 9 disclosed equity rounds
Darker bars = larger roundsFocus: Synthetic DNA manufacturing, custom nucleic acid libraries, and related hybridization/enzymatic technologies.
CPC B01J19/0046, C07K16/2869, C12N15/1093Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$67.90m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in chemistry & materials
CPC C12Q1/6886, C12Q1/6883, G16B25/10Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$16.95m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$518.45m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: Digital health data integration, remote patient monitoring, and HIPAA compliance automation
CPC G16H50/20, G06Q10/0639, G16H80/00Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$187.52m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: EEG-based seizure prediction, detection, and neurological condition monitoring technologies
CPC A61B5/291, A61B5/372, A61B5/6843Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$123.00m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in chemistry & materials
CPC C12Q1/6886Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$259.16m across 6 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$270.53m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: HVAC heating equipment and air‑handling cabinet components
CPC F24H9/148, F24H4/04, F24F13/20Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Genetically engineered herbicide‑resistant sorghum and alfalfa via ACC gene mutations
CPC A01H5/12, C12N15/8274, A01H5/10Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Life sciences companies in California founded in the last four years, newest first.
Hospital equipmentDeveloper of tankless dive gear and oxygen generation systems
Rare diseasesDeveloper of AI-enabled therapeutics for rare diseases with high unmet need
Developer of therapeutics focused on addressing unmet needs in renal disease
Founders
Details not available
Life sciences techProvider of AI-powered GxP validation and compliance solutions for life sciences
Founders
Details not available
Cannabis equipmentOnline retailer of custom packaging, lighters, and promotional products
Founders
Details not available
OncologyDeveloper of small-molecule therapeutics targeting kinases for cancer treatment
Founders
Details not available
Life sciences platforms and toolsDeveloper of RNA foundation models for precision medicine research applications
NeurologyDeveloper of brain-computer interfaces to maximize human ability, agency, experience
Life sciences platforms and toolsProvider of AI-native protein characterization platform for biopharma
Life sciences techDeveloper of therapies targeting autoimmune diseases by leveraging parasite biology
Provider of molecular diagnostic testing services for identifying cancer vulnerabilities
Life sciences techDeveloper of an AI regulatory platform for life sciences submissions
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Real-time multi-user AR streaming and collaborative 3D object interaction
CPC G02B27/0176, G06F3/0346, H04L65/60Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$5.30m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Companies with the most distinct news events in the last 24 months across the business press Fliar tracks.
Life sciences platforms and toolsDeveloper of technologies for analysis of genetic variation and function
Wearable technologyProvider of a wearable device for glucose monitoring
Rare diseasesDeveloper of therapeutics for the treatment of rare genetic diseases
Life sciences platforms and toolsDeveloper of diversified instruments for scientific and laboratory management
OncologyDeveloper of small molecule drugs for the treatment of cancer
Cardiac and vascular disordersDeveloper of medical devices for structural heart disease
Life sciences techVeeva Systems is a provider of cloud-based business solutions for the global life sciences industry.
Founders
Details not available
Developer of therapeutics for central nervous system disorders
ImmunotherapyDeveloper of drug delivery technologies for the treatment of various diseases
OphthalmologyManufacturer of implantable lenses for the eye with companion delivery systems
Life sciences platforms and toolsDeveloper of therapeutics to treat multiple diseases
OncologyDeveloper of drugs for hematologic disorders, cancer, and rare immune disease
Focus: High-throughput DNA sequencing hardware, reagents, and AI-driven base‑calling technologies.
CPC C12Q1/6869, C12Q1/6874, B01L3/502715Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$52.50m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Continuous glucose monitoring sensors, data transmission, and glycemic management software
CPC A61B5/14532, A61B5/14865, A61B5/1495Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$36.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Advanced analytical and fluidic instrumentation for mass spectrometry and bioassay automation.
CPC G01N30/20, G01N30/32, C12Q1/6806Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Small-molecule kinase inhibitors targeting cancer signaling pathways
CPC A61K31/47, C07D215/233, C07D471/04Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Cloud-based regulated content management and data querying for life sciences enterprise applications
CPC H04L63/083, G06F21/6218, G06F16/2365Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$44.70m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Enabling subcutaneous delivery of biologics via hyaluronidase and advanced injector devices
CPC A61K38/47, C12N9/2474, C12N9/2408Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Patents concentrated in computing, sensing & instrumentation
CPC G01N33/5008, A61K9/2009, C11B13/00Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
The most common specialisations among life sciences companies in California. Open a company to see what it sells, who runs it and how far it has come.
728 life sciences companies in California work in life sciences platforms and tools. Shown: the best-documented.
Life sciences platforms and toolsDevelops in-vivo animal model for R&D applications
Founders
Details not available
Life sciences platforms and toolsDeveloper of technologies for analysis of genetic variation and function
GenomicsDeveloper of single-cell, spatial, and in situ tools for high-resolution biological analysis
Founders
Details not available
Life sciences platforms and toolsDeveloper of a semiconductor-based DNA synthesis platform
GenomicsContract research organization for cell culture product and animal model manufacturer
Life sciences platforms and toolsManufacturer of flow cytometry systems for research applications
GenomicsDeveloper of instrument systems and software for real-time sequencing of single-molecules
GenomicsDeveloper of instruments for life sciences industries
GenomicsProvider of genome analysis solutions to researchers and clinicians
Life sciences platforms and toolsDeveloper of benchtop DNA sequencer for research applications
GenomicsDeveloper of high-throughput NGS instrument for research
Life sciences platforms and toolsDeveloper of high-performance enzymes for drug discovery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: High-throughput DNA sequencing hardware, reagents, and AI-driven base‑calling technologies.
CPC C12Q1/6869, C12Q1/6874, B01L3/502715Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$199.90m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Single-cell and spatial multi-omics technologies for high-throughput nucleic acid analysis
CPC C12Q1/6806, C12Q1/6837, C12Q1/6874Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$320.76m across 9 disclosed equity rounds
Darker bars = larger roundsFocus: Synthetic DNA manufacturing, custom nucleic acid libraries, and related hybridization/enzymatic technologies.
CPC B01J19/0046, C07K16/2869, C12N15/1093Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$132.00m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Advanced fluidics, imaging, and calibration technologies for high‑throughput flow cytometry
CPC G01N15/1404, G01N15/1436, G01N15/1434Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$395.00m across 5 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$40.53m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in transport & manufacturing processes
CPC B01L3/502738, B01L3/502707, C12Q1/686Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$124.20m across 7 disclosed equity rounds
Darker bars = larger roundsFocus: Iron-based nanoemulsion drug formulations and metal‑ion nanocluster delivery systems
CPC A61K33/26, A61K47/52, A61K9/1075Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$678.30m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Advanced optical flow cells, reagents, and data processing for next‑gen DNA sequencing
CPC C12Q1/6874, C12Q1/6869, G01N15/1436Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Patents concentrated in chemistry & materials
CPC C12Q1/6874, C12Q1/6869, C12Q1/6837Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$74.17m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Engineered biocatalytic enzymes for industrial synthesis of fine chemicals and pharmaceuticals
CPC C12N9/0006, C12N9/88, C12N9/1096Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
672 life sciences companies in California work in genomics. Shown: the best-documented.
Employee health itProvider of end-to-end Virtual clinic offering cancer-based solutions
GenomicsDeveloper of a platform for detection of cancer

OncologyDeveloper of a genomics-based diagnostic test for cancer

Natural language processingProvides AI-enabled data analytics tool for the healthcare industry

GenomicsVirtual eating disorder treatment and therapy, accessible and personalized care

Life sciences platforms and toolsDeveloper of technologies for analysis of genetic variation and function
OncologyDeveloper of cell-free DNA testing for oncology, women’s health, and organ health
GenomicsProvider of home-based genetic test for individuals
GenomicsDeveloper of digital sequencing technology for cancer detection
GenomicsDeveloper of single-cell, spatial, and in situ tools for high-resolution biological analysis
Founders
Details not available
Life sciences platforms and toolsDeveloper of a semiconductor-based DNA synthesis platform
GenomicsContract research organization for cell culture product and animal model manufacturer
US$491.44m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: Enabling cross-device social network content sharing and live streaming
CPC H04L12/1827, H04L65/60Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$138.97m across 4 disclosed equity rounds
Darker bars = larger rounds
Focus: Patents concentrated in chemistry & materials
CPC C12Q1/6886, C12N15/1093, G06Q30/0277Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$1.27m across 6 disclosed equity rounds
Darker bars = larger rounds
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Focus: AI-driven automation of clinical workflow and health‑expert conversational assistance.
CPC G16H10/20, G16H80/00Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: High-throughput DNA sequencing hardware, reagents, and AI-driven base‑calling technologies.
CPC C12Q1/6869, C12Q1/6874, B01L3/502715Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$152.10m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: Non‑invasive cfDNA sequencing for prenatal and cancer diagnostics and monitoring
CPC C12Q1/6883, C12Q1/6886, C12Q1/6869Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$189.56m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in computing, sensing & instrumentation
CPC G16B20/20, C12Q1/6827, C12Q1/6869Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$557.50m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Liquid biopsy cfDNA sequencing and analysis for cancer detection and monitoring
CPC C12Q1/6886, C12Q1/6869, C12Q1/6806Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$199.90m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Single-cell and spatial multi-omics technologies for high-throughput nucleic acid analysis
CPC C12Q1/6806, C12Q1/6837, C12Q1/6874Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$320.76m across 9 disclosed equity rounds
Darker bars = larger roundsFocus: Synthetic DNA manufacturing, custom nucleic acid libraries, and related hybridization/enzymatic technologies.
CPC B01J19/0046, C07K16/2869, C12N15/1093Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
670 life sciences companies in California work in life sciences tech. Shown: the best-documented.
Life sciences techProvider of an AI platform for patient safety and regulatory compliance

Life sciences techProvider of AI technology solutions for accelerating life sciences product development

Life sciences platforms and toolsDeveloper of technologies for analysis of genetic variation and function
Grc softwareDeveloper of software for governance risk and compliance management processes
Big data analyticsDeveloper of healthcare data platforms and artificial intelligence agent software
GenomicsProvider of a cloud-based bioinformatics platform for biotech research
Life sciences techValidation software for the life sciences companies
Healthcare itProvider of bioinformatics platform to find treatment for cancer and other diseases
Life sciences techProvider of a cloud based clinical trail management tool for researchers
OncologyProtein tracking and measuring tool for drug discovery
Sales force automationProvider of AI-powered solutions for healthcare provider engagement in life sciences
Big data analyticsAI-enabled platofrm for clinical trial data analytics

Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: High-throughput DNA sequencing hardware, reagents, and AI-driven base‑calling technologies.
CPC C12Q1/6869, C12Q1/6874, B01L3/502715Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$213.35m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: Enterprise governance platforms for hierarchical data traversal, visualization, and access control
CPC G06T11/26, G06F21/6227, G06F16/35Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$557.35m across 8 disclosed equity rounds
Darker bars = larger roundsFocus: Integrating and analyzing de‑identified healthcare data across clouds for clinical decision support
CPC G16H10/60, G06F21/6254, G06F8/36Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$411.90m across 8 disclosed equity rounds
Darker bars = larger roundsFocus: Cloud-based bioprocess workflow and molecular design data management platform.
CPC G05B19/41865, G16C20/40, G06F21/6227Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Risk‑based software for pharmaceutical manufacturing validation and lifecycle management
CPC G05B19/4155, G06Q10/0635, G06F8/71Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$607.58m across 10 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$518.45m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: Digital health data integration, remote patient monitoring, and HIPAA compliance automation
CPC G16H50/20, G06Q10/0639, G16H80/00Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$1.16bn across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Automated vehicle intrusion barriers for rapid security deployment
CPC E01F13/123, G21K1/043Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$90.70m across 7 disclosed equity rounds
Darker bars = larger roundsFocus: AI-driven omnichannel marketing and sales optimization platforms using contextual decision models
CPC G06Q10/063116, G06Q30/0201, G06Q30/0202Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$75.75m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Enterprise AI-driven data analytics for risk, employee, sentiment, and location optimization
CPC G06Q10/04, G06F17/30477, G06Q10/063Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
626 life sciences companies in California work in oncology. Shown: the best-documented.
GenomicsDeveloper of a platform for detection of cancer

OncologyDeveloper of a genomics-based diagnostic test for cancer

DermatologyProvider of drugs for treating cancer, infectious disease, and psoriasis

ImmunotherapyDeveloper of immunotherapies for the treatment of cancer and infectious diseases
OncologyDeveloper of therapeutic biologic drugs against cancer and other diseases

OncologyDeveloper of cell-free DNA testing for oncology, women’s health, and organ health
GenomicsDeveloper of digital sequencing technology for cancer detection
OncologyDeveloper of targeted antibody and T-cell therapeutics for treating multiple diseases
GenomicsDeveloper of genomics-based diagnostics for cancer
ImmunotherapyDeveloper of peptide-based vaccines for immunotherapy
Founders
Details not available
ImmunotherapyDeveloper of immunotherapy to treat cancer, infectious, and inflammatory diseases
OncologyTreatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology.
Founders
Details not available
US$138.97m across 4 disclosed equity rounds
Darker bars = larger rounds
Focus: Patents concentrated in chemistry & materials
CPC C12Q1/6886, C12N15/1093, G06Q30/0277Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$1.27m across 6 disclosed equity rounds
Darker bars = larger rounds
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$152.10m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: Non‑invasive cfDNA sequencing for prenatal and cancer diagnostics and monitoring
CPC C12Q1/6883, C12Q1/6886, C12Q1/6869Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$557.50m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Liquid biopsy cfDNA sequencing and analysis for cancer detection and monitoring
CPC C12Q1/6886, C12Q1/6869, C12Q1/6806Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$52.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$67.90m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in chemistry & materials
CPC C12Q1/6886, C12Q1/6883, G16B25/10Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$169.25m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Cell-based cancer immunotherapies and therapeutic vaccines targeting solid tumors.
CPC C12N5/0646, A61K40/15, A61K35/17Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$146.51m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: NK cell CAR immunotherapy development, epigenetic enhancement, and scalable cell manufacturing
CPC C12N5/0646, A61K35/17, A61K40/15Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$213.52m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: Therapeutics targeting HIF prolyl hydroxylase inhibition and immuno‑modulatory antibodies (galectin‑9, CCR8).
CPC C07D217/26, A61K31/472, C07K16/22Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
450 more company lists you can search, plus the Radar directory pages for each place.
No list matches. Try a shorter word.
We will reply with coverage, fields and pricing for your use case.
Filed revenue, profit and growth for every company on this page are available with a Radar account. Log in and you will come straight back here with all figures open.